论文部分内容阅读
Objective:The aim of this study was to investigate the expression of BRAF of prostate cancer,and to explore its relations with clinic-pathological factors.Methods:Immunohistochemistry was used to detect the expression of BRAF in 74 cases of prostate cancer,and 51 cases of benign prostate hyperplasia(BPH).Results:The positive rate of BRAF had significant difference between patients with prostate cancer and BPH(P < 0.05).The expression of BRAF was correlated with grade and stage of prostate cancer(P < 0.05),but not to age of onset(P > 0.05).Conclusion:The expression of BRAF may play a role in the tumorigenesis and progression of colorectal cancer.BRAF could be a factor to diagnose the typing of prostate cancers and predict the prognosis of prostate cancers.
Objective: The aim of this study was to investigate the expression of BRAF of prostate cancer, and to explore its relations with clinic-pathological factors. Methods: Immunohistochemistry was used to detect the expression of BRAF in 74 cases of prostate cancer, and 51 cases of benign prostate hyperplasia (BPH). Results: The positive rate of BRAF had significant difference between patients with prostate cancer and BPH (P <0.05). The expression of BRAF was correlated with grade and stage of prostate cancer (P <0.05) but not to age of onset (P> 0.05) .Conclusion: The expression of BRAF may play a role in the tumorigenesis and progression of colorectal cancer. BRAF could be a factor to diagnose the typing of prostate cancers and predict the prognosis of prostate cancers .